Critical care medicine Flashcards
1
Q
Reasons for admission
A
- Respiratory support
- Invasive monitoring e.g. pressure, cardiac function
- Renal support
- Decreased conscious level
2
Q
What are we trying to achieve
A
- The maintenance of oxygen perfusion to vital organs
- Removing or treating the causes of the problem
- Treating other problems that are produced
- allowing the body to recover
3
Q
How do we do this
A
- Airways/Breathing
- Circulation
- Sedation and analgesia
- Sepsis
4
Q
Cardiac output
A
5
Q
How do we measure cardiac function
A
- Indirect measures
- BP: Central venous, arterial
- For the left side of the heart
- LiDCO
- PiCCO
- Oesophageal Doppler
- Swan Ganz/ Pulmonary artery flotation catheters
6
Q
Circulatory failure
A
- Inadequate pre-load
- Maldistribution
- Anaphylaxis
- Septic shock
- Myocardial failure
- Systolic +/- diastolic dysfunction
7
Q
Inadequate pre-load
A
- Measurements
- Central Venous Pressure (CVP)
- Treatment: Give fluid
- Choice
- Crystalloid
- Colloid
8
Q
Maldistribution
A
- Measurement- low systemic vascular resistance (SVR)
- Also known as ‘afterload’ (for the left side of the heart)
- Treatment: Give a vasoconstrictor (Vasopressor)
9
Q
Receptor types
A
- Alpha 1 + 2- vasoconstriction of blood vessels
- Beta 1- Inotropic
- Beta 2
- Vasodilation of blood vessels
- Bronchodilator
10
Q
Noradrenaline
A
- Acts on a1 and b1 (i.e. primarily heart of vascular smooth muscle)
- Results in increased SVR and increased heart rate
- Adverse effects
- Mainly related to decreased organ perfusion leading to ischaemia (e.g. splanchnic bed, digits)
11
Q
Dopeamine (DA)
A
- Low dose- D1-dopaminergic receptors in vascular tissue esp. Renal, mesenteric and coronary beds- leads to vasodilation
- High dose- b1-receptors (i.e. heart)
- Also causes the release of noradrenaline which results in vasoconstriction
- Adverse effects
- Tachycardia
- Arrhythmias
- Myocardial ischaemia
12
Q
Vasopressin
A
- Acts on V1 receptors
- Causes profound vasoconstriction
13
Q
Myocardial failure
A
- Measurement: low cardiac output
- Treatment: Give an inotrope
- Choice
14
Q
Inotrope
A
- Ino = fibre
- trepein - to turn or influence
- Literally- to turn or affect muscle fibres
- Can be positive or negative
15
Q
Dobutamine
A
- B1- agonist (-&+) isomers
- a1- agonist0 (-) isomer
- a1- antagonist - (+) isomer
- B2- agonist
- Net result- Increase contractility, with some effect on rate
- Adverse effects
- Tachycardia & arrhythmias
- Can lead to increased myocardial oxygen consumpton, and hence ischaemia
- Can get tolerance